Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 2 , Pages 112-115 , June 2006

How to optimise topical photodynamic therapy in dermatology

References 

  1. Ibbotson SH. How we treat a superficial basal cell carcinoma with topical photodynamic therapy in Dundee. Photodiag Photodyn Therapy. 2006;3:128–131
  2. Sieroń A, et al. Photodynamic diagnosis (PDD) and photodynamic therapy in dermatology. Photodiag Photodyn Therapy. 2006;3:132–133
  3. Loncaster JA, Allan E. How to do it: photodynamic therapy in the management of a patient with Gorlin Syndrome. Photodiag Photodyn Therapy. 2006;3:134–137
  4. Morton CA, Brown SB, Collin S, et al. Guidelines for photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146(4):552–567
  5. Szeimies RM, Morton CA, Sidoroff A, Braathen LR. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Verereol. 2005;85:483–490
  6. Mitra A, Stables GI. Topical photodynamic therapy for non-melanoma skin cancer. Photodiag Photodyn Therapy. 2006;3:116–127
  7. Babilas P, Kohl E, Maisch T, et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006;154:712–718
  8. Tarstedt M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Dermato-Venereologica. 2005;85:424–428
  9. Morton CA, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134:248–249
  10. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolaevulinate vs surgery for nodular basal cell carcinoma. Results of a multicentre randomised prospective trial. Arch Dermatol. 2004;140:17–23
  11. Rhodes LE, de Rie M, Enström Y, et al. A randomized European comparison of excision surgery and MAL-PDT in nodular basal cell carcinoma: results from a 36-month follow-up. J Eur Acad Dermatol Venereol. 2005;19(S2):P08.69
  12. Soler AM, Warloe T, Berner A, et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl-5-aminlevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–471
  13. Basset-Seguin N, Ibbotson S, Emtestam L, et al. MAL-PDT versus cryotherapy in primary sBCC: results of a 36 month follow-up. Poster presented to the 13th Congress of the European Academy of Dermatology and Venereology, Florence, November, 2004.
  14. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen‘s disease: an effective addition to treatment: a pilot study. Dermatol Surg. 2004;30:63–66
  15. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape stripped normal skin. Arch Dermatol. 2003;139(9):1173–1177
  16. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006;154:969–976
  17. Gold MH. The evolving role aminolaevulinic acid hydrochloride with photodynamic therapy in photoageing. Cutis. 2002;69:8–13
  18. Goldman MP, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Surg Med. 2002;14(Suppl.):24

PII: S1572-1000(06)00075-5

doi: 10.1016/j.pdpdt.2006.05.001

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 2 , Pages 112-115 , June 2006

Article Tools